Comparing HR 546 → SR 300 — A Resolution recognizing the month of May 2026 as "Myositi...

Struck = only in HR 546 · added = only in SR 300.

Previous
Latest
LC 112 3266 House Resolution 546 th th th By:
PRINTER'S NO.
Representatives Hilton of the 48, Cooper of the 45 , Hawkins of the 27 , Mathiak of nd th the 82 , O’Steen of the 169 , and others A RESOLUTION Recognizing May 2025 as Myositis Awareness Month;
1669 THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE RESOLUTION Session of No.
and for other purposes.
300 2026 INTRODUCED BY PHILLIPS-HILL, MARTIN, HUGHES, HAYWOOD, VOGEL, STREET AND J.
WHEREAS, residents of Georgia are among those affected by myositis and other rare diseases, as nearly one in ten Americans have a rare disease;
WARD, MAY 1, 2026 REFERRED TO RULES AND EXECUTIVE NOMINATIONS, MAY 1, 2026 A RESOLUTION Recognizing the month of May 2026 as "Myositis Awareness Month" in Pennsylvania.
and WHEREAS, idiopathic inflammatory myopathies, collectively referred to as myositis, are rare, chronic, autoimmune muscle-wasting diseases that often feature debilitating muscle inflammation, pain, fatigue, and difficulty swallowing and can result in myositis-associated interstitial lung disease;
WHEREAS, Myositis is a rare, autoimmune disease that causes inflammation in the muscles, which can cause prolonged muscle fatigue and weakness;
and WHEREAS, more research is needed to identify the causes of and treatments for myositis, which includes anti-MDA5 autoantibody-positive myositis, antisynthetase syndrome, dermatomyositis, juvenile dermatomyositis, immune-mediated necrotizing myopathy, inclusion body myositis, and polymyositis;
and WHEREAS, The disease encompasses several conditions, including juvenile myositis, dermatomyositis and polymyositis;
and WHEREAS, myositis is difficult to diagnose, often leading to delayed treatment, and individuals with the disease frequently struggle to find healthcare providers with expertise in their condition;
as well as inclusion body myositis;
and H.
and WHEREAS, These diseases, sometimes referred to as inflammatory myopathies, can affect the internal organs, skin and multiple muscle groups of patients;
R.
and WHEREAS, An estimated 75,000 people in the United States are affected by all forms of myositis;
546 - 1 - LC 112 3266 WHEREAS, all who suffer from myositis experience a reduced quality of life, and no cure hasbeenfound;lifeexpectancyisoftenshortened,particularlyforthosewithinclusionbody myositis, and women and people of color with all forms of myositis experience pronounced health disparities;
and WHEREAS, Treatment for this rare autoimmune disease may include both nondrug and drug-based therapies, including immunosuppressants or corticosteroids, which slow the body's immune system and reduce the body's attack on its muscles, skin and organs;
and WHEREAS, the Myositis Association is the leading international patient advocacy organization serving the myositis community, focusing on patient services, education, research, and public awareness in the pursuit of a world without myositis.
and WHEREAS, Physical therapy also may be included as a treatment to help improve the patient's physical activity and quality of life;
NOW,THEREFORE,BEITRESOLVEDBYTHEHOUSEOFREPRESENTATIVESthat the members of this body recognize May 2025 as Myositis Awareness Month.
therefore be it RESOLVED, That the Senate recognize the month of May 2026 as "Myositis Awareness Month" in Pennsylvania;
BEITFURTHERRESOLVEDthattheClerkoftheHouseofRepresentativesisauthorized and directed to make appropriate copies of this resolution available for distribution to the public and the press.
and be it further RESOLVED, That the Senate raise awareness and support those affected by this rare, yet impactful, disease.
H.
20260SR0300PN1669 - 2 -
R.
546 - 2 -